Sepsis-induced vasoplegia--is vasopressin V1A-receptor a new target?
Knuefermann
Pascal
P
Boehm
Olaf
O
Baumgarten
Georg
G
Zacharowski
Kai
K
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D016207:Cytokines / Q000096:biosynthesis* / Q000378:metabolism; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism / Q000502:physiology*; D017483:Receptors, Vasopressin / Q000187:drug effects / Q000502:physiology*; D018805:Sepsis / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D012769:Shock / Q000209:etiology* / Q000378:metabolism
D065092:Antidiuretic Hormone Receptor Antagonists; D016207:Cytokines; D005938:Glucocorticoids; D016328:NF-kappa B; D017483:Receptors, Vasopressin